Dai Sheng-Yao, Xiao Zhen, Shen Fangfang, Lim Irene, Rao Jianghong
Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, California 94305, United States.
Department of Chemistry, Stanford University, Stanford, California 94305, United States.
J Am Chem Soc. 2025 Jan 15;147(2):2037-2048. doi: 10.1021/jacs.4c15644. Epub 2025 Jan 5.
Accumulation of misfolded proteins challenges cellular proteostasis and is implicated in aging and chronic disorders. Cancer cells, moreover, face an elevated level of basal proteotoxic stress; hence, exacerbating endoplasmic reticulum (ER) stress has been shown to induce programmed cell death while enhancing anticancer immunogenicity. We hypothesize that hydrophobic abiotic macromolecules can trigger a similar stress response. Most polymers and nanoparticles, however, are sequestered in endo/lysosomes after endocytosis, which prevents their interaction with the proteostasis machinery. We adopted an polymerization approach to synthesize polymers in cells with cell-permeable monomers. Specifically, we developed a biocompatible polycondensation between l-cysteine and 2-cyanobenzothiazole (CBT) with photochemical control to form insoluble poly(luciferin) aggregates. We identified that polymerization activates the BiP-PERK-CHOP pathway of the unfolded protein response and that the unresolved ER stress initiates a form of regulated cell death consistent with paraptosis. In addition, the dying cells emit damage-associated molecular patterns (DAMPs), indicating an immunogenic cell death that could potentiate antitumor immunity. Our results show that polymerization mimics misfolded protein aggregates to induce proteotoxic stress and cancer cell death, offering a novel therapeutic strategy to exploit cancer vulnerability.
错误折叠蛋白的积累对细胞蛋白质稳态构成挑战,并与衰老和慢性疾病有关。此外,癌细胞面临更高水平的基础蛋白毒性应激;因此,加剧内质网(ER)应激已被证明可诱导程序性细胞死亡,同时增强抗癌免疫原性。我们假设疏水性非生物大分子可以触发类似的应激反应。然而,大多数聚合物和纳米颗粒在胞吞作用后被隔离在内吞体/溶酶体中,这阻止了它们与蛋白质稳态机制的相互作用。我们采用一种聚合方法,用可穿透细胞的单体在细胞内合成聚合物。具体来说,我们开发了一种在l-半胱氨酸和2-氰基苯并噻唑(CBT)之间具有光化学控制的生物相容性缩聚反应,以形成不溶性聚(荧光素)聚集体。我们发现这种聚合激活了未折叠蛋白反应的BiP-PERK-CHOP途径,并且未解决的内质网应激引发了一种与副凋亡一致的程序性细胞死亡形式。此外,垂死细胞会释放损伤相关分子模式(DAMPs),表明存在可增强抗肿瘤免疫力的免疫原性细胞死亡。我们的结果表明,这种聚合模拟错误折叠的蛋白聚集体以诱导蛋白毒性应激和癌细胞死亡,为利用癌症易感性提供了一种新的治疗策略。